Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.

被引:48
|
作者
Leong T.T. [1 ]
Fearon U. [1 ]
Veale D.J. [1 ]
机构
[1] Department of Rheumatology, St. Vincent's University Hospital and The Conway Institute of Biomolecular and Biomedical Research, University College Dublin
关键词
Vascular Endothelial Growth Factor; Psoriasis; Infliximab; Pioglitazone; Psoriatic Arthritis;
D O I
10.1007/s11926-005-0044-5
中图分类号
学科分类号
摘要
Psoriasis is a common chronic dermatosis occurring in 2% of the population and associated with an inflammatory arthritis--psoriatic arthritis (PsA)--in up to 40% of cases. PsA accounts for approximately 15% of patients attending early synovitis clinics, therefore it represents the second most common diagnostic category after rheumatoid arthritis. There are a number of common pathogenic features that link the skin and the joint inflammatory processes. Angiogenesis appears to be a fundamental inflammatory response early in the pathogenesis and significant abnormalities of vascular morphology and angiogenic growth factors have been described in psoriasis and PsA. This paper will explore the recent published evidence to support the hypothesis that dysregulated angiogenesis provides a primary pathogenic mechanism in psoriasis skin and in the PsA joint.
引用
收藏
页码:325 / 329
页数:4
相关论文
共 50 条
  • [1] Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: A literature review
    Coates, Laura C.
    Anderson, R. Rox
    Fitzgerald, Oliver
    Gottlieb, Alice B.
    Kelly, Stephen G.
    Lubrano, Ennio
    Mcgonagle, Dennis G.
    Olivieri, Ignazio
    Ritchlin, Christopher T.
    Tan, Ai Lyn
    de Vlam, Kurt
    Helliwell, Philip S.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (07) : 1438 - 1442
  • [2] Insights into the pathogenesis of psoriasis and psoriatic arthritis
    Espinoza, LR
    van Solingen, R
    Cuellar, ML
    Angulo, J
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 316 (04) : 271 - 276
  • [3] HIGHER COMORBIDITY BURDEN IN EARLY PSORIATIC ARTHRITIS AS COMPARED TO EARLY RHEUMATOID ARTHRITIS: CLUES FOR PATHOGENESIS OF PSORIATIC DISEASE
    Ishchenko, A.
    Lories, R.
    Verschueren, P.
    De Vlam, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 45 - 45
  • [4] Burden of Disease: Psoriasis and Psoriatic Arthritis
    Wolf-Henning Boehncke
    Alan Menter
    American Journal of Clinical Dermatology, 2013, 14 : 377 - 388
  • [5] The Interleukin-17 Pathway in Psoriasis and Psoriatic Arthritis: Disease Pathogenesis and Possibilities of Treatment
    Marina Frleta
    Stefan Siebert
    Iain B. McInnes
    Current Rheumatology Reports, 2014, 16
  • [6] The Interleukin-17 Pathway in Psoriasis and Psoriatic Arthritis: Disease Pathogenesis and Possibilities of Treatment
    Frleta, Marina
    Siebert, Stefan
    McInnes, Iain B.
    CURRENT RHEUMATOLOGY REPORTS, 2014, 16 (04)
  • [7] Treatment of psoriasis and psoriatic arthritis
    Papoutsaki M.
    Costanzo A.
    BioDrugs, 2013, 27 (Suppl 1) : 3 - 12
  • [8] Infliximab in psoriasis and psoriatic arthritis
    Papoutsaki M.
    Osório F.
    Morais P.
    Torres T.
    Magina S.
    Chimenti S.
    Costanzo A.
    BioDrugs, 2013, 27 (Suppl 1) : 13 - 23
  • [9] Infliximab for psoriasis and psoriatic arthritis
    Antoni, C
    Manger, B
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (06) : S122 - S125
  • [10] Disease mechanisms in psoriasis and psoriatic arthritis.
    Costello P.
    FitzGerald O.
    Current Rheumatology Reports, 2001, 3 (5) : 419 - 427